Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration

Imagem de Miniatura
Arquivos
art_CREDICO_Alcohol_drinking_and_head_and_neck_cancer_risk_2020.PDF (1.17 MB)
Citações na Scopus
62
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGERNATURE
Autores
CREDICO, Gioia Di
POLESEL, Jerry
MASO, Luigino Dal
PAULI, Francesco
TORELLI, Nicola
LUCE, Daniele
RADOI, Loredana
MATSUO, Keitaro
SERRAINO, Diego
BRENNAN, Paul
Citação
BRITISH JOURNAL OF CANCER, v.123, n.9, p.1456-1463, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Alcohol is a well-established risk factor for head and neck cancer (HNC). This study aims to explore the effect of alcohol intensity and duration, as joint continuous exposures, on HNC risk. Methods Data from 26 case-control studies in the INHANCE Consortium were used, including never and current drinkers who drunk <= 10 drinks/day for <= 54 years (24234 controls, 4085 oral cavity, 3359 oropharyngeal, 983 hypopharyngeal and 3340 laryngeal cancers). The dose-response relationship between the risk and the joint exposure to drinking intensity and duration was investigated through bivariate regression spline models, adjusting for potential confounders, including tobacco smoking. Results For all subsites, cancer risk steeply increased with increasing drinks/day, with no appreciable threshold effect at lower intensities. For each intensity level, the risk of oral cavity, hypopharyngeal and laryngeal cancers did not vary according to years of drinking, suggesting no effect of duration. For oropharyngeal cancer, the risk increased with durations up to 28 years, flattening thereafter. The risk peaked at the higher levels of intensity and duration for all subsites (odds ratio = 7.95 for oral cavity, 12.86 for oropharynx, 24.96 for hypopharynx and 6.60 for larynx). Conclusions Present results further encourage the reduction of alcohol intensity to mitigate HNC risk.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/41014
Referências
  1. Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579
  2. Benhamou S, 2004, INT J CANCER, V112, P901, DOI 10.1002/ijc.20474
  3. Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154
  4. Boing AF, 2011, J EPIDEMIOL COMMUN H, V65, P709, DOI 10.1136/jech.2009.097691
  5. Bosetti C, 2003, CANCER EPIDEM BIOMAR, V12, P1091
  6. Bravi F, 2013, BRIT J CANCER, V109, P2904, DOI 10.1038/bjc.2013.667
  7. Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003
  8. Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007
  9. Cui Y, 2006, INT J CANCER, V118, P714, DOI 10.1002/ijc.21413
  10. D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497
  11. Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x
  12. Di Credico G., 2018, THESIS
  13. Di Credico G, 2019, ORAL ONCOL, V94, P47, DOI 10.1016/j.oraloncology.2019.05.006
  14. Di Maso M, 2020, STAT METHODS MED RES, V29, P854, DOI 10.1177/0962280219848471
  15. Divaris K, 2010, CANCER CAUSE CONTROL, V21, P567, DOI 10.1007/s10552-009-9486-9
  16. DOLL R, 1978, CANCER RES, V38, P3573
  17. Elahi A, 2002, CARCINOGENESIS, V23, P1229, DOI 10.1093/carcin/23.7.1229
  18. Ferraroni M, 1996, INT J EPIDEMIOL, V25, P775, DOI 10.1093/ije/25.4.775
  19. FRANCESCHI S, 1990, CANCER RES, V50, P6502
  20. Franceschi S, 2000, INT J CANCER, V85, P787, DOI 10.1002/(SICI)1097-0215(20000315)85:6<787::AID-IJC8>3.0.CO;2-6
  21. Fu Y, 2020, PLASMA RES EXP, V2
  22. Gelman A., 2013, BAYESIAN DATA ANAL, V3rd edn
  23. Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2
  24. Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1
  25. Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179
  26. Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797
  27. Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg107, 10.1093/jnci/djg/107]
  28. International Agency for Research on Cancer, 2010, IARC MON EV CARC RIS, V96
  29. International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS
  30. Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca
  31. Levi F, 1998, INT J CANCER, V77, P705, DOI 10.1002/(SICI)1097-0215(19980831)77:5<705::AID-IJC8>3.0.CO;2-Z
  32. Lubin JH, 2007, AM J EPIDEMIOL, V166, P479, DOI 10.1093/aje/kwm089
  33. Lubin JH, 2012, CANCER EPIDEMIOL, V36, P306, DOI 10.1016/j.canep.2012.03.001
  34. Lubin JH, 2009, AM J EPIDEMIOL, V170, P937, DOI 10.1093/aje/kwp222
  35. Luce D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-928
  36. Muscat JE, 1996, CANCER RES, V56, P5192
  37. NEGRI E, 1993, CANCER EPIDEM BIOMAR, V2, P189
  38. O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403
  39. Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185
  40. Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431
  41. POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215
  42. Polesel J, 2008, INT J CANCER, V122, P2398, DOI 10.1002/ijc.23385
  43. Praud D, 2016, INT J CANCER, V138, P1380, DOI 10.1002/ijc.29890
  44. R Development Core Team, 2019, R LANG ENV STAT COMP
  45. ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305
  46. Rosenblatt KA, 2004, CANCER RES, V64, P4049, DOI 10.1158/0008-5472.CAN-03-3425
  47. Ruppert D. M., 2003, CAMBRIDGE SERIES STA
  48. Sarich P, 2019, ALCOHOL CLIN EXP RES, V43, P710, DOI 10.1111/acer.13981
  49. Schantz SP, 1997, LARYNGOSCOPE, V107, P765, DOI 10.1097/00005537-199706000-00011
  50. Seitz HK, 2004, INT J CANCER, V108, P483, DOI 10.1002/ijc.11600
  51. Smith EM, 1998, LARYNGOSCOPE, V108, P1098, DOI 10.1097/00005537-199807000-00027
  52. Stan Development Team, 2017, STAN MOD LANG US GUI
  53. Suzuki T, 2006, CANCER SCI, V97, P760, DOI 10.1111/j.1349-7006.2006.00232.x
  54. Szymanska K, 2011, CANCER CAUSE CONTROL, V22, P1037, DOI 10.1007/s10552-011-9779-7
  55. van Osch FHM, 2019, EPIDEMIOLOGY, V30, P458, DOI 10.1097/EDE.0000000000000964
  56. WHO, 2018, GLOB STAT REP ALC HL
  57. Winn DM, 2015, ORAL DIS, V21, P685, DOI 10.1111/odi.12342
  58. Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X
  59. Zhang ZD, 2005, CANCER EPIDEM BIOMAR, V14, P1188, DOI 10.1158/1055-9965.EPI-04-0501
  60. ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P235, DOI 10.1007/BF00117475

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/28
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/06